Salma Kahtan Jabbour MD
Assistant Professor, Radiation Oncology, UMDNJ-Robert Wood Johnson Medical School
Join to View Full Profile
195 Little Albany StRadiation OncologyNew Brunswick, NJ 08901
Phone+1 732-235-3939
Fax+1 732-235-7493
Dr. Jabbour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Maryland School of MedicineClass of 2001
Certifications & Licensure
NJ State Medical License 2006 - 2025
PA State Medical License 2004 - 2014
American Board of Radiology Radiation Oncology
Clinical Trials
- Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas Start of enrollment: 2023 Mar 16
Roles: Contact
- Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer Start of enrollment: 2021 Feb 11
Roles: Contact, Principal Investigator
- Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma Start of enrollment: 2022 Jul 25
Roles: Contact, Principal Investigator
- Join now to see all
Publications & Presentations
PubMed
- Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.Salma K Jabbour, Kristin A Higgins, Sue S Yom, Karyn A Goodman
International Journal of Radiation Oncology, Biology, Physics. 2024-10-01 - Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radia...Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, Krishnan R Patel, Randall J Kimple
The Lancet. Oncology. 2024-10-01 - 1 citationsPhase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortiu...Jyoti Malhotra, Alberto Chiappori, Naomi Fujioka, Nasser H Hanna, Lawrence E Feldman
Lung Cancer. 2024-09-01
Authored Content
- Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non–Small Cell Lung Cancer Are Associated with Decreases in Overall SurvivalMay 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
